BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19278961)

  • 41. What is the role of microbial biotechnology and genetic engineering in medicine?
    Santos-Beneit F
    Microbiologyopen; 2024 Apr; 13(2):e1406. PubMed ID: 38556942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Large-scale comparison of machine learning methods for profiling prediction of kinase inhibitors.
    Wu J; Chen Y; Wu J; Zhao D; Huang J; Lin M; Wang L
    J Cheminform; 2024 Jan; 16(1):13. PubMed ID: 38291477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of YES1 signaling in tumor therapy resistance.
    Zhou H; Sun D; Tao J; Xu M; Zhang X; Hou H
    Cancer Innov; 2023 Jun; 2(3):210-218. PubMed ID: 38089407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nintedanib in an elderly non-small-cell lung cancer patient with severe steroid-refractory checkpoint inhibitor-related pneumonitis: A case report and literature review.
    Pan L; Meng F; Wang W; Wang XH; Shen H; Bao P; Kang J; Kong D
    Front Immunol; 2022; 13():1072612. PubMed ID: 36703957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches.
    Muscogiuri G; Barrea L; Cantone MC; Guarnotta V; Mazzilli R; Verde L; Vetrani C; Colao A; Faggiano A;
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emerging roles of protein palmitoylation and its modifying enzymes in cancer cell signal transduction and cancer therapy.
    Liu Z; Xiao M; Mo Y; Wang H; Han Y; Zhao X; Yang X; Liu Z; Xu B
    Int J Biol Sci; 2022; 18(8):3447-3457. PubMed ID: 35637973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options.
    Qin C; Huang M; Pan Y; Li Y; Long W; Liu Q
    Brain Tumor Pathol; 2021 Jul; 38(3):156-172. PubMed ID: 33903981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identifying Novel Drug Targets by iDTPnd: A Case Study of Kinase Inhibitors.
    Naveed H; Reglin C; Schubert T; Gao X; Arold ST; Maitland ML
    Genomics Proteomics Bioinformatics; 2021 Dec; 19(6):986-997. PubMed ID: 33794377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An antitumor peptide RS17-targeted CD47, design, synthesis, and antitumor activity.
    Wang X; Wang Y; Hu J; Xu H
    Cancer Med; 2021 Mar; 10(6):2125-2136. PubMed ID: 33629544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular Delivery of Cytotoxic Agents via Integrin Activation.
    Cirillo M; Giacomini D
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33467465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HGF/c-Met signaling regulates early differentiation of placental trophoblast cells.
    Ma Y; Yu X; Li YX; Wang YL
    J Reprod Dev; 2021 Apr; 67(2):89-97. PubMed ID: 33455972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Interactions of Nintedanib and Oral Anticoagulants-Molecular Mechanisms and Clinical Implications.
    Grześk G; Woźniak-Wiśniewska A; Błażejewski J; Górny B; Wołowiec Ł; Rogowicz D; Nowaczyk A
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advancement in research and therapy of
    Tao J; Sun D; Dong L; Zhu H; Hou H
    Cancer Cell Int; 2020; 20():492. PubMed ID: 33061844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of the Activation Status of the Akt/mTOR Signalling Pathway on the Clinical Behaviour of Synovial Sarcoma: Retrospective Analysis of 174 Patients at a Single Institution.
    Li YX; Ding SS; Wen WJ; Han L; Wang HQ; Shi HY
    Cancer Manag Res; 2020; 12():1759-1769. PubMed ID: 32210617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel Peptide CM 7 Targeted c-Met with Antitumor Activity.
    Xia C; Wang Y; Liu C; Wang L; Gao X; Li D; Qi W; An R; Xu H
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31973231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance.
    Das PK; Pillai S; Rakib MA; Khanam JA; Gopalan V; Lam AKY; Islam F
    Stem Cell Rev Rep; 2020 Apr; 16(2):397-412. PubMed ID: 31965409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel CDKs inhibitors for the treatment of solid tumour by simultaneously regulating the cell cycle and transcription control.
    Wang X; Deng K; Wang C; Li Y; Wang T; Huang Z; Ma Y; Sun P; Shi Y; Yang S; Fan Y; Xiang R
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):414-423. PubMed ID: 31899991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening.
    Wang Z; Li W; Jing H; Ding M; Fu G; Yuan T; Huang W; Dai M; Tang D; Zeng M; Chen Y; Zhang H; Zhu X; Peng Y; Li Q; Yu WF; Yan HX; Zhai B
    Theranostics; 2019; 9(22):6690-6705. PubMed ID: 31588244
    [No Abstract]   [Full Text] [Related]  

  • 59. The Mediterranean Diet and Cancer: What Do Human and Molecular Studies Have to Say about It?
    Hernáez Á; Estruch R
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31505794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-1-3p suppresses the epithelial-mesenchymal transition property in renal cell cancer by downregulating Fibronectin 1.
    Liu J; Huang Y; Cheng Q; Wang J; Zuo J; Liang Y; Yuan G
    Cancer Manag Res; 2019; 11():5573-5587. PubMed ID: 31417307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.